Find clinical trials for Endometrial Cancer in Phoenix, AZ
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Endometrial Cancer trials near Phoenix, AZ, USA:
The purpose of this study is to investigate the efficacy and safety of the lifileucel regimen in participants with previously treated endometrial...
Phase 2
Phoenix, Arizona, United States and 11 other locations
Researchers are looking for new ways to treat people with endometrial cancer (EC) who have previously received treatment with plati...
Phase 3
Phoenix, Arizona, United States and 242 other locations
standard medical care for the treatment of recurrent or progressive endometrial cancer (EC) following prior therapy. There is an eq...
Phase 3
Phoenix, Arizona, United States and 119 other locations
participants with recurrent or primary advanced (Stage III or IV) endometrial cancer....
Phase 3
Phoenix, Arizona, United States and 168 other locations
to evaluate the efficacy and safety of ACR-368 as monotherapy or with ultra-low dose gemcitabine (ULDG) sensitization in participants with endometrial...
Phase 2
Phoenix, Arizona, United States and 90 other locations
drug LY3484356 alone or in combination with other anticancer therapies is safe and effective in participants with advanced or metastatic breast cancer...
Phase 1
Phoenix, Arizona, United States and 73 other locations
This study will test the safety, including side effects, and determine the characteristics of a drug called Rina-S in participants with solid tumors...
Phase 1, Phase 2
Phoenix, Arizona, United States and 65 other locations
The purpose of this study is to characterize the safety, tolerability, and efficacy of IDE161 as a single agent and in combination with pembrolizumab.
Phase 1
Phoenix, Arizona, United States and 26 other locations
tolerability, PK, pharmacodynamic (what the drug does to the body), and antitumor activity of CGT6297 in adult participants with advanced solid tumors...
Phase 1
Scottsdale, Arizona, United States and 3 other locations
) antibody (balstilimab), and to assess the maximum tolerated dose (MTD) in participants with advanced solid tumors. This study will also de...
Phase 1
Scottsdale, Arizona, United States and 17 other locations
Clinical trials
Research sites
Resources
Legal